Phase I and Clinical Pharmacology Services

Learn about our Phase I services

Discover the Worldwide Difference

We specialize in designing and executing customized studies that drive your drug development forward. Our Phase I and clinical pharmacology services are tailored to meet the specific needs of your program, whether it’s a challenging study design or a unique objective.

Our commitment starts with our first conversation and lasts throughout our entire working relationship. You’ll see it in the dedication of our staff, the flexibility and availability of our leadership team, and the services you receive.

It is our mission to deliver quality data faster, allowing your asset to accelerate to the next step.

0 %
0
0 %

Comprehensive Support for Every Step of Your Clinical Journey

No two studies are the same, and neither are their paths to success. We’re committed to offering bespoke support at every stage of your clinical development journey.

  • Concept and Regulatory Approach
  • Protocol Design
  • Program Development
  • Worldwide CPU Site
  • QA Approved Phase I Global Site Network
  • Recruitment of Healthy Patient Populations
  • Customizable PK and PD collection kits and bulk supplies
  • Kits supplied with labeled tubes on a per-visit basis
  • Training materials included as part of kits
  • GLP and Part 11 Compliant; Support Regulated Bioanalysis (Clinical Studies, GCP)
  • Small and Large Molecule Bioanalysis, Pharmacokinetic Analysis and Reports
  • DEA and RAD-licensed
  • First-in-Human 
  • Integrated SAD and MAD (includes FE/DDI/BA/EPQT)
  • Drug-Drug Interaction
  • BE/BA
  • Food and Meal Timing Effect
  • PK/PD
  • AME/Mass Balance/Metabolite Profiling
  • Renal Impairment
  • Hepatic Impairment
  • Expert Precision QT and Thorough QT Evaluations Impairment
  • POC Studies in Patients
  • CSF Collection and Analysis
  • Specialty Procedures (Biopsies, NG tube, and unique routes of administration)
  • PK/PD/Tox Analysis and Reports
  • Consultation Services
  • Phase I Focus and Expertise
  • Dedicated Phase I Teams
  • Protocols and Synopsis
  • Informed Consent Document
  • Clinical Study Reports

We’re here to help you succeed

WorldwideEdge™

We know our people, processes, and technologies can play a key role in your asset’s success. This understanding is at the heart of our continuous innovation initiative—WorldwideEdge™.

Award-Winning Phase I Services 

Clinical Leader announced the 2024 Leadership Awards, supported by data from ISR Reports, naming Worldwide Clinical Trials the highest-rated Phase I Service Provider for Overall User Preference and the highest-rated Phase I Service Provider for Data Management.

A Tailored Program, Every Time 

We understand that no two Phase I trials are the same. That’s why we offer flexible, customized solutions through our state-of-the-art bioanalytical laboratory, full-service, fit-for-purpose clinical pharmacology unit, and specialized pharmacy services. With an unwavering commitment to excellence, we deliver high-quality data faster, ensuring your asset progresses seamlessly to the next phase without compromise.

“I think that what differentiates [Worldwide Clinical Trials] from other CROs is how efficient they operate, how responsive they resolve or do their issue-resolution. Those are the things that I can think of immediately that make me like to work with midsized CROs.”

Small Biopharmaceutical Customer Director of Clinical Operations

“It was an open, honest, but enthusiastic work environment that [Worldwide Clinical Trials] really provided. They paid attention to us as a small company…and they made us feel like one of their more important clients, even if we weren’t, and that was all the difference.”

Small Biopharmaceutical Customer Senior Vice President of Program Operations

“I thought very highly of Worldwide Clinical Trials. I thought they were a good, solid CRO and certainly would have them included in any upcoming clinical development work.”

Early Phase: Small Biotech Customer Head of Regulatory Affairs

“We really appreciate the strong collaborative partnership we’ve developed with Worldwide, which is based on shared accountability. I see us awarding them more studies in the future.”

Clinical Stage Biotech Company Sr. Vice President of Clinical Development and CMS

Our Dedicated Phase I Experts

Validated Assays

Worldwide Clinical Trials has access to more than 2,000 validated assays.